Pharmaceutical manufacturers of Levamisole hydrochloride

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.

Over the last few years, we have emerged as India’s largest animal health company with presence in 100+ countries. Our logotype is inspired by nature and its different forms and shapes -from a microscopic view of the skin texture to footprint of a chosen animal. The circular shape evokes the idea of protection and control. It’s a closed and perfect shape that is naturally balanced, reminiscing the brand idea “Animals’ Source of Health”. Pronounced A-lee-vee-rah, the name is a variant of two Latin words Elvira, word for ‘white, pure, clean’ and Alleviare, word for ‘relief’. It speaks about our commitment to improving animals’ life and well-being at every stage. We are Alivira! Our focus on R&D is taking us even further, and we are committed to applying cutting-edge resources to improve health and well-being at every stage of animals’ lives. All along our processes, we are committed to quality, but moreover, we are committed to safety. That is our guarantee for effective medicines.

We are the primary manufacturer of Avermectin worldwide and the leading producer of Ivermectin in Asia, with an annual production that constitutes half of the total in China. Additionally, we hold the top position as the producer for Tiamulin, Eprinomectin, and Emamectin Benzoate in China.

Nanjing Pharmaceutical Factory Co., Ltd. (NPF) was established in 1935. Following this, the organization carried out relocations of its facilities, relocating the finished dosage plant to Nanjing Xingang Industrial Park in 2001 and the API plant to Nanjing Chemical Industrial Park in 2003. Over time, NPF has evolved into a sizable and integrated producer with robust research and development capabilities for API, finished dosage, and pharmaceutical intermediates. The API facility spans 120,000 square meters and comprises 6 specialized and versatile workshops, along with extensive land for potential expansion. Manufacturing and quality systems are operated in compliance with cGMP regulations. Nanjing Well Pharmaceutical Group Co., Ltd. was formed in 2000 through the comprehensive conversion of the original Nanjing Well Chemical Co., Ltd. Since its inception, the firm has concentrated on the research and development, manufacturing, and marketing of pharmaceutical excipients and synthetic lubricating base oils, supplying customers with advanced new products such as high-safety and multifunctional pharmaceutical excipients and synthetic lubricating base oils with outstanding performance. The company's pharmaceutical excipient products are utilized in various pharmaceutical dosage forms, including injections, oral administration, and external applications.